Watertown, MA– Landmark Bio, a rising force in the development and manufacturing of advanced therapies, has been acquired by Artis BioSolutions, a newly established...
LEXINGTON, Mass.-- ldeyra Therapeutics (Nasdaq: ALDX) announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the...
Cambridge, MA- BioMed Realty, a Blackstone portfolio company and the largest private operator of life science real estate, announced the acquisition of a majority...
BOSTON— The Boston Life Sciences, Biotech, Pharma & Medical Facilities Conference 2025 is set to feature a distinguished lineup of industry leaders, including Ben...
PALO ALTO, Calif.— Science Exchange, a leader in life sciences procurement and supplier management software, has announced the acquisition of HappiLabs, a Chicago-based company...
CAMBRIDGE, Mass. — Charles River Laboratories International, Inc. and Valo Health, Inc. announced the identification of a promising drug candidate for the treatment of...
BOSTON – Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) provided key updates on its Type 1 Diabetes (T1D) portfolio, which includes progress on clinical trials for...
Recent Comments